DA Davidson Forecasts AMETEK’s Q4 Earnings (NYSE:AME)

AMETEK, Inc. (NYSE:AME) – Research analysts at DA Davidson issued their Q4 2024 earnings estimates for AMETEK in a research report issued to clients and investors on Friday, November 1st. DA Davidson analyst M. Summerville anticipates that the technology company will post earnings of $1.84 per share for the quarter. The consensus estimate for AMETEK’s current full-year earnings is $6.76 per share.

AMETEK (NYSE:AME) last announced its quarterly earnings data on Thursday, October 31st. The technology company reported $1.66 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.04. The firm had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.71 billion. AMETEK had a net margin of 19.27% and a return on equity of 16.88%. The business’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.64 earnings per share.

Several other research analysts have also recently commented on the stock. Royal Bank of Canada lowered their price target on shares of AMETEK from $216.00 to $215.00 and set an “outperform” rating for the company in a report on Friday, August 2nd. TD Cowen cut shares of AMETEK from a “hold” rating to a “sell” rating in a report on Monday, October 7th. Redburn Atlantic upgraded shares of AMETEK to a “strong-buy” rating in a report on Friday, August 2nd. Truist Financial boosted their price target on shares of AMETEK from $219.00 to $221.00 and gave the stock a “buy” rating in a report on Friday. Finally, StockNews.com cut shares of AMETEK from a “buy” rating to a “hold” rating in a report on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $195.00.

AMETEK Trading Down 2.7 %

Shares of AME stock opened at $178.43 on Monday. The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.76 and a current ratio of 1.39. AMETEK has a fifty-two week low of $141.26 and a fifty-two week high of $186.32. The stock has a market capitalization of $41.31 billion, a P/E ratio of 31.09, a price-to-earnings-growth ratio of 3.01 and a beta of 1.16. The company has a 50 day moving average price of $169.17 and a 200 day moving average price of $168.86.

AMETEK Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were given a dividend of $0.28 per share. The ex-dividend date was Monday, September 16th. This represents a $1.12 annualized dividend and a dividend yield of 0.63%. AMETEK’s dividend payout ratio is presently 19.51%.

Insider Transactions at AMETEK

In related news, Director Steven W. Kohlhagen sold 1,460 shares of the company’s stock in a transaction on Wednesday, September 25th. The shares were sold at an average price of $171.59, for a total value of $250,521.40. Following the completion of the sale, the director now owns 23,349 shares in the company, valued at $4,006,454.91. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.61% of the company’s stock.

Institutional Trading of AMETEK

Several institutional investors and hedge funds have recently bought and sold shares of the business. JPMorgan Chase & Co. raised its position in AMETEK by 48.4% in the 1st quarter. JPMorgan Chase & Co. now owns 7,075,565 shares of the technology company’s stock valued at $1,294,121,000 after purchasing an additional 2,306,535 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in AMETEK by 0.7% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 6,536,231 shares of the technology company’s stock valued at $1,195,478,000 after buying an additional 44,899 shares during the period. Bank of New York Mellon Corp increased its stake in AMETEK by 34.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 3,602,753 shares of the technology company’s stock valued at $600,615,000 after buying an additional 926,657 shares during the period. Boston Partners increased its stake in AMETEK by 3.0% in the 1st quarter. Boston Partners now owns 3,063,588 shares of the technology company’s stock valued at $560,278,000 after buying an additional 90,271 shares during the period. Finally, Flossbach Von Storch AG increased its stake in AMETEK by 3.4% in the 1st quarter. Flossbach Von Storch AG now owns 2,673,507 shares of the technology company’s stock valued at $488,984,000 after buying an additional 87,477 shares during the period. Hedge funds and other institutional investors own 87.43% of the company’s stock.

About AMETEK

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.